About Craig Eagle
Craig Eagle is a director at OS Therapies.
Form D filings also name Craig Eagle as a director at Telomir Pharmaceuticals.
Craig Eagle reports to the SEC as a director or officer of 5 public companies, including Guardant Health (GH), Telomir Pharmaceuticals (TELO) and Q/c Technologies (QCLS).
Craig Eagle first appears on SEC filings in 2012.
Experience
This experience comes from SEC filings. The years are when the filings name Craig Eagle in the role, so the role may have started earlier or lasted longer.
GI
Guardant Health, Inc.
Chief Medical Officer
2021 – 2026 · Public company (GH)
QI
Q/c Technologies, Inc.
Director
2021 – 2023 · Public company (QCLS)
AI
Assured Pharmacy, Inc.
Director
2012 · Public company (APHY)
Key Colleagues at Startups
The people Craig Eagle works with at each company, as listed on that company's latest Form D.
OS Therapies Inc · Form D, Oct 23, 2026
PR
Paul Romness
Chairman, President and Chief Executive Officer
RP
Robert Petit
Chief Medical Officer and Chief Scientific Officer
FI
Francis Knuettel II
Chief Financial Officer
JC
John Ciccio
Director
AD
Avril McKean Dieser
Director
OJ
Olivier Jarry
Director
TS
Theodore Search
Director
KC
Kerry Clem
Chief Commercial Officer
Telomir Pharmaceuticals, Inc. · Form D, Apr 3, 2023
TT
Tuck Talhia
Director
DV
David Vorhoff
Director
JM
James McNulty
Treasurer, Chief Financial Officer and Secretary
CC
Chris Chapman
President, Chief Executive Officer and Chairman
HM
Hugh McColl
Director
JU
Jude Uzonwanne
Director